IKS Health's innovative solution orchestrates a roll out of critical operations functions into a unified and efficient connected workflow
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
Majority of organizations are looking to increase investments in public and hybrid cloud
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
Gefion, powered entirely by renewable energy, boasts more than 1,500 NVIDIA GPUs
The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
India plays a critical role in Bristol Myers Squibb’s global strategy
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Subscribe To Our Newsletter & Stay Updated
